Context Therapeutics Inc. (NASDAQ: CNTX) is one of the best penny stocks under $1 to buy now. Earlier in June, Context ...

Mersana Therapeutics Inc. (NASDAQ: MRSN) is one of the best penny stocks under $1 to buy now. Earlier in June, Mersana Therapeutics presented additional positive interim Phase 1 clinical data for ...

Pfizer Inc. (NYSE: PFE) announced today the completion of a global, ex-China, licensing agreement with 3SBio, Inc. (01530.HK) ...

A different study presented at the 2025 ASCO Annual Meeting showed that one specific diet may benefit people with colon ...

The biologic and biosimilar era has brought about more clinical trials in rheumatology than ever before, and with increasing ...

Bonilla, MD, MSEd, discusses the significant advancements and ongoing efforts in integrating artificial intelligence into oncology.

Replimune's RP1 treatment for advanced melanoma faces FDA rejection due to trial design issues, despite promising results ...

Nearly one-third of patients with pancreatic cancer missed germline testing, with the disparities tied to race, insurance, and care setting.

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

ASCO convened a panel of experts to update the clinical guidelines for fertility preservation in men, women, and adolescents with cancer.

Erica Campbell chose a mastectomy. That choice gave her power — and helped her make peace with her biggest regret.

ASCO discussant Krina Patel, MD, MSc, of the University of Texas MD Anderson Cancer Center in Houston, noted that "ciltacabtagene autoleucel is the first potential functional cure for patients ...